Kronos Bio, Inc. (KRON)
0.880
0.00 (0.00%)
Inactive · Last trade price
on Jun 20, 2025
Kronos Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 9.19 | 9.85 | 6.29 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 21.15% | 56.62% | - | - | - | - | Upgrade
|
| Gross Profit | 9.19 | 9.85 | 6.29 | - | - | - | Upgrade
|
| Selling, General & Admin | 25.41 | 27.68 | 42.29 | 46.47 | 41.8 | 19.07 | Upgrade
|
| Research & Development | 34.38 | 45.6 | 81.2 | 90.65 | 109.6 | 38.98 | Upgrade
|
| Operating Expenses | 59.79 | 73.28 | 123.49 | 137.12 | 151.4 | 58.04 | Upgrade
|
| Operating Income | -50.6 | -63.43 | -117.2 | -137.12 | -151.4 | -58.04 | Upgrade
|
| Interest Expense | - | - | - | - | - | -3.89 | Upgrade
|
| Interest & Investment Income | 5.85 | 6.81 | 9.4 | - | 0.32 | 0.9 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 3.91 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -44.75 | -56.62 | -107.8 | -133.2 | -151.08 | -61.04 | Upgrade
|
| Merger & Restructuring Charges | -7.36 | -10.75 | -1.71 | - | - | - | Upgrade
|
| Asset Writedown | -12.38 | -18.71 | -3.16 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -27.41 | Upgrade
|
| Pretax Income | -64.49 | -86.08 | -112.67 | -133.2 | -151.08 | -88.44 | Upgrade
|
| Net Income | -64.49 | -86.08 | -112.67 | -133.2 | -151.08 | -88.44 | Upgrade
|
| Net Income to Common | -64.49 | -86.08 | -112.67 | -133.2 | -151.08 | -88.44 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 60 | 58 | 56 | 55 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 60 | 58 | 56 | 55 | 16 | Upgrade
|
| Shares Change (YoY) | 3.52% | 4.03% | 2.75% | 2.64% | 236.38% | 208.35% | Upgrade
|
| EPS (Basic) | -1.07 | -1.43 | -1.95 | -2.37 | -2.76 | -5.43 | Upgrade
|
| EPS (Diluted) | -1.07 | -1.43 | -1.95 | -2.37 | -2.76 | -5.43 | Upgrade
|
| Free Cash Flow | -54.38 | -65.44 | -79.26 | -91.5 | -122.18 | -47.48 | Upgrade
|
| Free Cash Flow Per Share | -0.90 | -1.09 | -1.37 | -1.63 | -2.23 | -2.92 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | - | - | - | Upgrade
|
| Operating Margin | -550.46% | -644.11% | -1863.88% | - | - | - | Upgrade
|
| Profit Margin | -701.53% | -874.08% | -1791.87% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -591.55% | -664.49% | -1260.51% | - | - | - | Upgrade
|
| EBITDA | -49.14 | -61.72 | -115.07 | -134.85 | -149.42 | -57.21 | Upgrade
|
| D&A For EBITDA | 1.46 | 1.72 | 2.14 | 2.27 | 1.98 | 0.84 | Upgrade
|
| EBIT | -50.6 | -63.43 | -117.2 | -137.12 | -151.4 | -58.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.